However, the 55L risk variant did not appear to significantly affect the PON-1 enzyme functions in T2D Asian populations as it was not associated with increased CHD risk, disease severity, or alter the FBG level [49]. This evidence concerns the gene PON1 and type 2 diabetes mellitus.